{"filing": {"accession": "0001437749-26-028069", "cik": "0001787740", "ticker": "VBIO", "company_name": "Valion Bio, Inc.", "form_type": "10-Q", "filing_type": "10-Q", "filing_date": "2026-08-14", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1787740/000143774926028069/0001437749-26-028069-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1787740/000143774926028069/0001437749-26-028069-index.htm", "period_of_report": "2026-06-30"}, "html_url": "/api/filings/000143774926028069/stream", "exhibits": [{"exhibit_number": "31.1", "exhibit_type": "31", "description": "Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.", "filename": "ex_976048.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000143774926028069/ex_976048.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "31.2", "exhibit_type": "31", "description": "Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.", "filename": "ex_976049.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000143774926028069/ex_976049.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "32.1", "exhibit_type": "32", "description": "Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.", "filename": "ex_976050.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000143774926028069/ex_976050.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "3.1", "exhibit_type": "3", "description": "Certificate of Amendment to the Amended and Restated Certificate of Incorporation, filed April 22, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826003161/tivic_ex0301.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "Tumim Form of Pre-Funded Warrant", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826000877/tivic_ex0401.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.1", "exhibit_type": "10", "description": "Common Stock Purchase Agreement by and between Tivic Health Systems, Inc. and Tumim Stone Capital, LLC, dated February 6, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826000877/tivic_ex1001.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.2", "exhibit_type": "10", "description": "Registration Rights Agreement by and between Tivic Health Systems, Inc. and Tumim Stone Capital, LLC, dated February 6, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826000877/tivic_ex1002.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.4", "exhibit_type": "10", "description": "Building Lease Agreement by and between Velocity Bioworks, Inc. and TPB Merchants Ice LLC, dated March 13, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826001781/tivic_ex1001.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.5", "exhibit_type": "10", "description": "Lease by and between Velocity Bioworks, Inc. and Merchants Ice II, LLC, dated March 9, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826001781/tivic_ex1002.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.6", "exhibit_type": "10", "description": "Sublease by and among Velocity Bioworks, Inc., Texas Research and Technology Foundation, and TPB Merchants Inc LLC, signed March 13, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826001781/tivic_ex1003.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.8", "exhibit_type": "10", "description": "Second Amendment to Valion Bio, Inc. Amended and Restated 2021 Equity Incentive Plan, dated May 28,,2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1787740/000168316826004481/valion_ex1001.htm", "category": "contracts", "incorporated_by_reference": true}], "sections": [{"section_name": "part_1_item_1", "section_title": "Financial Statements", "start_position": 4433, "end_position": 141982}, {"section_name": "part_1_item_2", "section_title": "Management \u2019 s Discussion and Analysis of Financial Condition and Results of Operations", "start_position": 141982, "end_position": 210445}, {"section_name": "part_1_item_3", "section_title": "Quantitative and Qualitative Disclosures about Market Risk", "start_position": 210445, "end_position": 210530}, {"section_name": "part_1_item_4", "section_title": "Controls and Procedures", "start_position": 210530, "end_position": 216582}, {"section_name": "part_2_item_1", "section_title": "Legal Proceedings", "start_position": 216582, "end_position": 217197}, {"section_name": "part_2_item_1a", "section_title": "Risk Factors", "start_position": 217197, "end_position": 221561}, {"section_name": "part_2_item_2", "section_title": "Unregistered Sales of Equity Securities and Use of Proceeds", "start_position": 221561, "end_position": 221972}, {"section_name": "part_2_item_3", "section_title": "Defaults upon Senior Securities", "start_position": 221972, "end_position": 222031}, {"section_name": "part_2_item_4", "section_title": "Mine Safety Disclosures", "start_position": 222031, "end_position": 222089}, {"section_name": "part_2_item_5", "section_title": "Other Information", "start_position": 222089, "end_position": 222548}, {"section_name": "part_2_item_6", "section_title": "Exhibits", "start_position": 222548, "end_position": 226951}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware(State or other jurisdiction of incorporation or organization)81-4016391(I.R.S. Employer Identification No.)"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "\u2610 Large accelerated Filer\u2610 Accelerated Filer"}, {"table_index": 4, "table_type": "financial", "caption": null, "header_text": "Condensed Consolidated Balance Sheets as of June 30, 2026 (unaudited) and December 31, 20252"}, {"table_index": 5, "table_type": "financial", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 6, "table_type": "financial", "caption": null, "header_text": "Three Months EndedSix Months Ended"}, {"table_index": 7, "table_type": "financial", "caption": null, "header_text": "Mezzanine Equity -Redeemable Convertible Series B Preferred StockMezzanine Equity -Redeemable Convertible Series C Preferred StockPreferred StockCommon StockAdditional Paid-in CapitalAccumulated Defic"}, {"table_index": 8, "table_type": "financial", "caption": null, "header_text": "Mezzanine Equity -Redeemable Convertible Series B Preferred StockMezzanine Equity -Redeemable Convertible Series C Preferred StockPreferred StockCommon StockAdditional Paid-in CapitalAccumulated Defic"}, {"table_index": 9, "table_type": "financial", "caption": null, "header_text": "Six Months Ended"}, {"table_index": 13, "table_type": "financial", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 14, "table_type": "financial", "caption": null, "header_text": "Three Months EndedSix Months Ended"}, {"table_index": 15, "table_type": "financial", "caption": null, "header_text": "Six Months Ended"}, {"table_index": 17, "table_type": "financial", "caption": null, "header_text": "ASSETSDecember 10, 2025"}, {"table_index": 19, "table_type": "financial", "caption": null, "header_text": "As of June 30, 2026 (unaudited)"}, {"table_index": 20, "table_type": "financial", "caption": null, "header_text": "As of December 31, 2025"}, {"table_index": 21, "table_type": "text", "caption": null, "header_text": "Amount"}, {"table_index": 22, "table_type": "text", "caption": null, "header_text": "Amount"}, {"table_index": 24, "table_type": "financial", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 26, "table_type": "financial", "caption": null, "header_text": "Right-of-use assets, operating lease$9,835"}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": "Three Months EndedSix Months Ended"}, {"table_index": 28, "table_type": "text", "caption": null, "header_text": "Fiscal YearTotal Payments"}, {"table_index": 30, "table_type": "text", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 32, "table_type": "text", "caption": null, "header_text": "EventPayment"}, {"table_index": 33, "table_type": "text", "caption": null, "header_text": "EventPayment"}, {"table_index": 36, "table_type": "financial", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 38, "table_type": "text", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 39, "table_type": "text", "caption": null, "header_text": "Amount"}, {"table_index": 40, "table_type": "text", "caption": null, "header_text": "For the Years Ended December 31,Total Payments"}, {"table_index": 46, "table_type": "text", "caption": null, "header_text": "June 30,December 31,"}, {"table_index": 48, "table_type": "text", "caption": null, "header_text": "Class of SharesNumber of Warrant SharesExercise Price of WarrantsExpiration Date of Warrants"}, {"table_index": 50, "table_type": "text", "caption": null, "header_text": "OutstandingExercisable"}, {"table_index": 51, "table_type": "text", "caption": null, "header_text": "Number of SharesWeighted- Average Grant Date Fair Value Per Share"}, {"table_index": 52, "table_type": "text", "caption": null, "header_text": "Three Months EndedSix Months Ended"}, {"table_index": 54, "table_type": "text", "caption": null, "header_text": "Three Months EndedSix Months Ended"}, {"table_index": 55, "table_type": "text", "caption": null, "header_text": "Six Months Ended"}, {"table_index": 57, "table_type": "financial", "caption": null, "header_text": "As of June 30, 2026As of December 31, 2025"}, {"table_index": 58, "table_type": "financial", "caption": null, "header_text": "Three Months Ended June30, 2026Three Months Ended June 30, 2025"}, {"table_index": 60, "table_type": "text", "caption": null, "header_text": "EventPayment"}, {"table_index": 61, "table_type": "text", "caption": null, "header_text": "EventPayment"}, {"table_index": 66, "table_type": "text", "caption": null, "header_text": "\u25cfOn April 28, we rebranded as Valion Bio to reflect the Company's transformation into a late-stage biopharmaceutical company and changed our ticker symbol to VBIO."}, {"table_index": 67, "table_type": "financial", "caption": null, "header_text": "Three Months Ended June 30,For the Six Months Ended"}, {"table_index": 69, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 71, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 76, "table_type": "text", "caption": null, "header_text": "\u25cfour efforts to enhance operational systems and hire additional personnel to support finance, sales, marketing, operations and development of our product candidates and satisfy our obligations as a pu"}, {"table_index": 77, "table_type": "text", "caption": null, "header_text": "Six Months Ended"}, {"table_index": 88, "table_type": "exhibit_index", "caption": null, "header_text": "ExhibitNumberExhibit descriptionIncorporatedby Reference(Form Type)Filing DateFiled herewith"}, {"table_index": 89, "table_type": "exhibit_index", "caption": null, "header_text": "*Furnished herewith."}, {"table_index": 90, "table_type": "text", "caption": null, "header_text": "Date: August 14, 2026By:/s/ Michael Handley"}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 75}